United Community Banks, Inc. (UCB) News
Follow United Community Banks, Inc. (UCB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 19 public stories across 13 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
STOXX 600 Posts Biggest Drop in Three Weeks, Falling More Than 1%
Europe's STOXX 600 fell more than 1% to 637.74, weighed by bank shares as oil prices climbed and French bond yields rose.
EQUITY | Oct 22, 2026, 05:18 PM UTC
M
UCB Raises Annual Guidance for Second Time This Year; Shares Jump 13%
UCB cited strong U.S. demand for its Bimzelx drug as it raised annual guidance for the second time this year. Shares rose 13% in European morning trading, erasing year-to-date losses.
EARNINGS | Oct 22, 2026, 08:10 AM UTC
M
UCB Raises 2026 Guidance on Strong US Bimzelx Sales
UCB said stronger-than-expected US sales of Bimzelx drove its upgraded 2026 financial outlook. The available report truncates before giving the updated growth figures.
EARNINGS | Oct 22, 2026, 05:10 AM UTC
M
United Community Banks Reports Q3 Operating EPS of $0.77
United Community Banks reported third-quarter operating earnings of $0.77 per share, up from $0.71 in the previous quarter. Core loans grew 10% annualized, and the company expects fourth-quarter EPS of $0.80 to $0.83.
EQUITY | Oct 20, 2026, 01:15 PM UTC
M
UCB Q3'26 Earnings Preview: EPS Estimates
UCB is scheduled to report Q3'26 results on October 20 before the market opens. Revenue and EPS estimates were provided.
EQUITY | Oct 19, 2026, 11:01 AM UTC
M
UCB Q3'26 results expected October 20; estimates provided
United Community Banks is set to report Q3'26 results before the market opens on October 20. The source gives revenue and EPS estimates.
EQUITY | Oct 13, 2026, 11:00 AM UTC
L
UCB: New Data Supports Earlier Use Of Bimzelx For Treating Hidradenitis Suppurativa
Ucb SA EURONEXT:UCB
NEWS | Sep 30, 2026, 05:03 AM UTC
H
Weekly Recap: BIMZELX-driven H1 growth and galvokimig midstage readout
UCB S.A. (EURONEXT:UCB) ramped H1 growth and raised guidance on BIMZELX momentum and expanding access, while pipeline progress across atopic dermatitis, epilepsy and T—cell engagers and a midstage galvokimig readout next
NEWS | Sep 28, 2026, 05:01 AM UTC
L
UCB Likely to Focus on Early-Stage Assets for Next Deals — Market Talk
UCB's portfolio offers growth potential into the next decade after the acquisitions of Candid Therapeutics and Neurona, so the Belgian drugmaker's next deals might target early-stage assets, Bank of America analysts say.
NEWS | Sep 24, 2026, 02:33 PM UTC
L
DA Davidson raises United Community Banks price target to $42.00
DA Davidson raised its price target for United Community Banks to $42.00 per share from $40.00, maintaining a Buy rating, according to the Benzinga ratings action as relayed by TradingView News.
EQUITY | Sep 09, 2026, 07:24 PM UTC
L
UCB maintained at neutral by Piper Sandler
Piper Sandler maintains a neutral rating on UCB.
EQUITY | Sep 09, 2026, 05:30 PM UTC
M
UCB gets FDA Breakthrough Status for Cimzia in APS pregnancy
UCB received FDA Breakthrough Status for Cimzia in APS pregnancy.
REGULATION | Sep 09, 2026, 05:08 AM UTC
L
UCB cites Navitas sale cash, acquisitions and talent investment for growth
UCB says a Navitas sale and securities repositioning generated $2.0 billion in cash and improved capital ratios, while share repurchases and a Peach State acquisition support EPS growth.
EARNINGS | Sep 08, 2026, 11:58 AM UTC
M
UCB completes balance-sheet repositioning, boosts buyback authorization
UCB completed a major balance-sheet repositioning and sold Navitas, redeploying proceeds into higher-yielding assets to reduce interest-rate risk and improve earnings. It increased share repurchase authorization and reit
CENTRAL_BANK | Sep 08, 2026, 11:58 AM UTC
M
United Community Banks completes $2.0 billion Navitas sale
United Community Banks completed the sale of Navitas for approximately $2.0 billion in cash, yielding a 7% premium to par.
REGULATION | Sep 01, 2026, 08:44 PM UTC
L
UCB names Dr. Jeff Beisler-Snell head of International Banking and Capital Markets
UCB appoints Dr. Jeff Beisler-Snell as Head of International Banking and Capital Markets, according to TradeXchange Newsdesk.
EQUITY | Aug 25, 2026, 03:25 PM UTC
L
UCB names Tom Speir new Chief Financial Officer
UCB (UCB) appoints Tom Speir as its new Chief Financial Officer, according to a company personnel announcement.
EQUITY | Aug 19, 2026, 12:01 PM UTC
L
United Community names Tom Speir chief financial officer
United Community names Tom Speir as its new chief financial officer, with no catalyst or timing details supplied in the alert.
EQUITY | Aug 19, 2026, 12:00 PM UTC
L
UCB appoints Sean Simpson as Chief Commercial Banking Officer
UCB appoints Sean Simpson as Chief Commercial Banking Officer, according to TradeXchange Newsdesk.
EQUITY | Aug 13, 2026, 08:21 PM UTC